Medco/Merck Contract Gets New Spin; Renegotiation May Avert Zocor Impact
Executive Summary
Medco's renegotiation of its rebate agreement with Merck may have allowed the pharmacy benefit manager to avoid loss of rebates accompanying Zocor'slooming patent expiration